Kollagenosen bei Jugendlichen

详细信息    查看全文

• 作者：Dr. J. Peitz ; Dr. I. Tantcheva-Poór
• 关键词：Lupus erythematosus ; Juvenile dermatomyositis ; Systemic scleroderma ; Mixed connective tissue disease ; Adolescent ; Skin
• 刊名：Der Hautarzt
• 出版年：2016
• 出版时间：April 2016
• 年：2016
• 卷：67
• 期：4
• 页码：271-278
• 全文大小：616 KB
• 参考文献：1.Ardoin SP, Schanberg LE (2005) The management of pediatric systemic lupus erythematosus. Nat Clin Pract Rheumatol 1(2):82–92CrossRef PubMed
  2.Arkin L, Ansell L, Rademaker A et al (2015) The natural history og pediatric-onset lupus erythematosus. J Am Acad Dermatol 72:628–633CrossRef PubMed
  3.Barsalou J, Levy DM, Silverman ED (2013) An update on childhood-onset systemic lupus erythematosus. Curr Opin Rheumatol 25(5):616–622CrossRef PubMed
  4.Chiu YE, Vora SS, Laxer RM et al (2014) Connective tissue disease. In: Tom WL (Hrsg) Severe skin diseases in children. Beyond topical treatment. Springer, Heidelberg
  5.Daldon P, Lage R (2011) Linear chronic discoid lupus erythematosus following the lines of Blaschko. An Bras Dermatol 86:553–556CrossRef PubMed
  6.Dressler F, Frosch M, Mönkemöller K et al (2011) Results of the German ESPED-Recording of new patients with juvenile dermatomyositis (JDM). Klin Padiatr 223:280–282CrossRef PubMed
  7.Falcini F, Nacci F (2007) Systemic lupus erythematosus in the young: the importance of a transition clinic. Lupus 16:613–617CrossRef PubMed
  8.Ferraz MB, Goldenberg J, Hilario MO et al (1994) Evaluation of the 1982 ARA lupus criteria data ser in pediatric patients. Clin Exp Rheumatol 12:83–87PubMed
  9.Foeldvari I, Nihtyanova SI, Werk A, Denton CR (2010) Characteristics of patients with juvenile onset systemic sclerosis in an adult single-centre cohort. J Rheumatol 37:2422–2426CrossRef PubMed
  10.Foeldvari I (2008) Update on pediatric systemic sclerosis: similarities and differences from adult disease. Curr Opin Rheumatol 20:608–612CrossRef PubMed
  11.Frosch M, Dressler F (2013) AWMF Leitlinie 027–058: juvenile Dermatomyositis. AWMF, Düsseldorf
  12.Häfner R, Michels H, Haas JP (2013) AWMF Leitlinie 027–062 Mischkollagenosen. AWMF, Düsseldorf
  13.Hoffmann IE, Lawverys BR, De Keyser F et al (2009) Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus. Ann Rheum Dis 68:412–415CrossRef
  14.Kuhn A, Bonsmann G, Anders HJ et al (2015) Diagnostik und Therapie des systemischen Lupus erythematodes. Dtsch Arztebl 25:423–432
  15.Lovell DJ, Lindsley CB, Rennebohm RM, Ballinger SH, Bowyer SL, Giannini EH (1999) Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. Arthritis Rheum 42(10):2213–2219CrossRef PubMed
  16.Martini G, Foeldvari I, Russo R et al (2006) Systemic sclerosis in childhood: clinical and immunological features of 153 patients in an international database. Arthritis Rheum 54:3971–3978CrossRef PubMed
  17.Martini G, Vittadello F (2009) Kasapcopur 0 et al. Factors affecting survival in juvenile systemic sclerosis. Rheumatology (Oxford) 408:119–122
  18.Ravelli A, Ruperto N, Martini A (2005) Outcome in juvenile onset systemic lupus erythematosus. Curr Opin Rheumatol 17:568–573CrossRef PubMed
  19.Rider LG, Lindsley CB, Cassidy JT (2011) Juvenile dermatomyositis. In: Cassidy JT, Petty RE, Lindsley LRMCB (Hrsg) Textbook of pediatric rheumatology, 6. Aufl. Elsevier Saunders, Philadelphia, S 375–413CrossRef
  20.Rider LG (2003) Calcinosis in juvenile dermatomyositis: pathogenesis and current therapies. Ped Rheumatol Online J 1:119–133
  21.Sag E, Tartaglione A, Batu ED et al (2014) Performance of the new SLICC classification criteria in childhood systemic lupus erythematosus: a multicenter study. Clin Exp Rheumatol 32(3):440–444PubMed
  22.Sammaritano LR (2014) Contraception in patients with systemic lupus erythematosus and antiphospholipid syndrome. Lupus 23:1242–1245CrossRef PubMed
  23.Silva CA, Aikawa NE, Pereira RM et al (2015) Management considerations for childhood-onset systemic lupus erythematosus patients and implication on therapy. Expert Rev Clin Immunol 15:1–13
  24.Sundel R, Solomons N, Group LLALMS (2012) Efficacy of mycophenolate mofetil in adolescent patients with lupus nephritis: evidence from a two-phase, prospective randomized trial. Lupus 21(13):1433–1443CrossRef PubMed
  25.Swart JF, Wulffraat NM (2008) Diagnostic workup for mixed connective tissue disease in childhood. Isr Med Assoc J 10(8–9):650–652PubMed
  26.Thon A (2013) Dermatomyositis. In: Wagner N, Dannecker G (Hrsg) Pädiatrische Rheumatologie, 2. Aufl. Springer Medizin, Heidelberg
  27.Tucker LB, Uribe AG, Fernandez M et al (2008) Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study with LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus 17:314–322CrossRef PubMed PubMedCentral
  28.Yokota S, Imagawa T, Katakura S, Itoh SI, Mitsuda T, Fujikawa S, Aihara Y (1997) Mixed connective tissue disease in childhood: a nationwide retrospective study in Japan. Acta Paediatr Jpn 39(2):273–276CrossRef PubMed
  29.Zulian F, Woo P, Athreya BH et al (2007) The Pediatric Rheumatology European Society/ American College of Rheumatology/ European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis. Arthritis Rheum 57(2):203–212CrossRef PubMed
  
• 作者单位：Dr. J. Peitz (1) (2)
  Dr. I. Tantcheva-Poór (3)
  
  1. Abteilung Kinder- und Jugendmedizin, Asklepios Klinik, Sankt Augustin, Deutschland
  2. Klinik und Poliklinik für Kinder- und Jugendmedizin, Uniklinik Köln, Köln, Deutschland
  3. Klinik und Poliklinik für Dermatologie und Venerologie, Uniklinik Köln, Kerpener Str. 62, 50937, Köln, Deutschland
  
• 刊物主题：Dermatology; Immunology; Allergology; Proctology;
• 出版者：Springer Berlin Heidelberg
• ISSN：1432-1173

文摘

In this article we provide a brief review of systemic lupus erythematosus, juvenile dermatomyositis, systemic scleroderma, and mixed connective tissue disease in adolescents. As skin manifestations often belong to the presenting symptoms and may have a significant impact on the quality of life, dermatologists play an important role in the management of patients with connective tissue diseases. Early diagnosis and therapy onset are crucial for the patients’ long-term outcome.